Related Experiment Videos
Flunarizine in long-term migraine prophylaxis: clinical evidence
C Colucci D'Amato1, A Colucci D'Amato, V Alfano
1Department of Neurologic Sciences, First School of Medicine, University of Naples, Italy.
Abstract:
The aim of our study was to evaluate the efficacy of long-term migraine prophylaxis with flunarizine. The efficacy of the drug was evaluated on the basis of the frequency, pain severity and duration of migraine attacks. Frequency, the most modified parameter, was reduced to about half of the pre-treatment level in one to three months time. The condition remained more or less stable from the third treatment month onwards. The results showed remarkable efficacy of long-term prophylaxis with flunarizine, and the response was better in younger patients with a short history of migraine.
Insights
Flunarizine effectively reduces migraine frequency and severity for long-term prevention. This migraine prophylaxis showed better results in younger patients with shorter migraine histories.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine is a common neurological disorder.
- Long-term prophylaxis is crucial for managing frequent migraine attacks.
Purpose of the Study:
- To assess the long-term effectiveness of flunarizine for migraine prophylaxis.
- To analyze the impact of flunarizine on migraine frequency, pain severity, and duration.
Main Methods:
- Prospective evaluation of flunarizine treatment in migraine patients.
- Monitoring of key migraine parameters including frequency, severity, and duration.
Main Results:
- Flunarizine significantly reduced migraine frequency by approximately 50% within 1-3 months.
- Migraine parameters stabilized after the third month of treatment.
- Younger patients with a shorter history of migraine showed a better response to flunarizine.
Conclusions:
- Long-term flunarizine prophylaxis demonstrates remarkable efficacy in migraine management.
- Flunarizine is a viable option for long-term migraine prevention, particularly in specific patient demographics.